{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:47:09Z","timestamp":1794750429700,"version":"4.9.1"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":10493,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1980,8]]},"abstract":"<jats:p>The in vitro properties of 5 factor VIII preparations (AHF\u2010Kabi, Hemofil Hyland, AHF\u2010Profilate Abbott, Kryobulin Immuno and Factorate High Purity Armour) and an ordinary cryoprecipitate were studied with reference to factor VIII clotting activity (VIII:C), factor VIII clotting antigen (VIILCAg), factor VIII related antigen (VIIIR:Ag) (EI, IRMA, CIE), ristocetin cofactor activity (VIIIR:RCF), fibrinogen and factor XIII. All the preparations with the exception of Factorate had higher levels of VIII:CAg than VIII:C indicating inactivation of the biological activity of VIII:C during the procedure. AHF\u2010Kabi (fraction I\u20100) and the cryoprecipitate, the only preparations capable of normalising the defect in patients with von Willebrand's disease, showed the same level of VIIIR:Ag determined by EI and by IRMA, while all the other preparations (i.e. cryoprecipitates purified further in different ways) had considerably lower levels of VIIIR:Ag determined by IRMA than by EL Based on these in vitro techniques it seems to be possible to predict which preparations can be used successfully in patients with von Willebrand's disease, while no such conclusions can be made from VIIIR:RCF determinations.<\/jats:p><jats:p>EI yielded similar concentrations of factor XIII<jats:italic>a<\/jats:italic>subunit in all the preparations tested. 3 functional assays showed high factor XIII activities in AHF\u2010Kabi but low or no activities in the others.<\/jats:p><jats:p>Thus, considerable differences were found of the in vitro properties of the proteins in 5 factor VIII concentrates and a cryoprecipitate. The action of proteases and the techniques used in the purification procedure are probably of crucial importance for the properties of the various factors.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1980.tb01593.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T20:13:44Z","timestamp":1280952824000},"page":"340-349","source":"Crossref","is-referenced-by-count":27,"title":["Characteristics of the Factor VIII Protein and Factor XIII in Various Factor VIII Concentrates"],"prefix":"10.1111","volume":"24","author":[{"given":"Inga Marie","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Stenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","unstructured":"AllainJ P VerroustF.&SoulierJ P(1979)Comparative in vitro and in vivo study of various factor VIII preparations.VIIth Internat Congr on Thrombosir and Haemostasis London p65(abstract).","DOI":"10.1055\/s-0039-1684422"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood.V51.2.281.281","article-title":"Effects of enzymatic degradation on the subunit composition and biologic properties of human factor VIII","volume":"51","author":"Atichartakarn V.","year":"1978","journal-title":"Blood"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","unstructured":"BarrowcliffeT W Kemball\u2010CookG. MorrisG. HoltJ C&PeakeI R(1979)Factor VIII\u2010related activities in therapeutic concentrates.VIIth Int Congr on Thrombosis and Haemostasis London p71(abstract).","DOI":"10.1055\/s-0039-1684436"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(66)92985-0"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.236.24.2770"},{"key":"e_1_2_1_7_1","first-page":"415","article-title":"Purification of human and bovine fibrinogen","volume":"10","author":"Blomb\u00e4ck B.","year":"1956","journal-title":"Arkiv Kemi"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jama.1968.03140350023005","article-title":"A new high potency glycine\u2010precipitated antihemophilic factor (AHF) concentrate: Treatment of classical hemophilia and hemophilia with inhibitors","volume":"250","author":"Brinkhous K M","year":"1968","journal-title":"J A M A"},{"key":"e_1_2_1_9_1","first-page":"96","article-title":"Heterogeneity of human factor VIII. II. Characterization of forms of factor VIII binding to platelets in the presence of ristocetin","volume":"92","author":"Doucet\u2010de Bru\u00efne M H M","year":"1978","journal-title":"J Lab Clin Med"},{"issue":"124","key":"e_1_2_1_10_1","first-page":"29","article-title":"Crossed immunoelectrophoresis","author":"Ganrot P O","year":"1972","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197409000-00002"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1978.tb16281.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(79)90078-1"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(80)90329-1"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1979.tb02802.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1979.tb02847.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(78)90256-6"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5822.317"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1978.tb02898.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(72)90074-7"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106061"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1975.tb53319.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(73)90038-8"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","unstructured":"MontgomeryR R(1979)Specific factor VIII fragmentation in commercial factor VIII concentrates.VIIth Internat Congr on Thrombosis and Haemostasis London p65(abstr).","DOI":"10.1055\/s-0039-1684421"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(78)90105-6"},{"key":"e_1_2_1_26_1","volume-title":"Haemorrhagic and Thrombotic Diseases","author":"Nilsson I M","year":"1974"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0038-1646712","article-title":"International Committee Communications. Report of the Working Party on Factor VIII Related Antigens","volume":"39","author":"Nilsson I M","year":"1978","journal-title":"Thromb-Haemostas"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1957.tb00532.x"},{"issue":"379","key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0954-6820.1962.tb18848.x","article-title":"Haemophilia in Sweden. VI. Treatment of haemophilia A with the human antihaemophilic factor preparation (fraction I\u20100)","author":"Nilsson I M","year":"1962","journal-title":"Acta Med Scand"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1977.tb01028.x"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0308-2261(21)00067-9","article-title":"von Willebrand's disease today","volume":"8","author":"Nilsson I M","year":"1979","journal-title":"Clin Haematol"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657018"},{"key":"e_1_2_1_33_1","article-title":"Report of the Subcommittee on Factor VIII Activities","author":"Nilsson I M","year":"1980","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_34_1","first-page":"297","article-title":"Determination of fibrinogen and fibrinogenolytic activity","volume":"8","author":"Nilsson I M","year":"1962","journal-title":"Thromb Diath Haemorrh"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood.V41.1.105.105","article-title":"Effects of plasmin on human factor VIII (AHF)","volume":"41","author":"Pasquini R.","year":"1973","journal-title":"Blood"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-0038-1649240","article-title":"Abnormal factor VIII related antigen (F VIIIRAG) in von Willebrand's disease (vWd): Decreased precipitation by concanavalin A","volume":"37","author":"Peake I R","year":"1977","journal-title":"Thromb Haemostas (Stuttg)"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb01131.x"},{"key":"e_1_2_1_38_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood.V21.2.221.221","article-title":"The importance of activation of anti\u2010haemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity","volume":"21","author":"Rapaport S I","year":"1963","journal-title":"Blood"},{"key":"e_1_2_1_39_1","first-page":"475","volume-title":"Handbook of hemophilia","author":"Roberts H R","year":"1975"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03533.x"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(75)90081-X"},{"issue":"238","key":"e_1_2_1_42_1","article-title":"von Willebrand's disease in Sweden","author":"Silwer J.","year":"1973","journal-title":"Acta Paediatr Scand"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.220.10.1352"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-2697(79)80177-3"},{"key":"e_1_2_1_45_1","first-page":"64","article-title":"Purification of antihemophilic factor (factor VIII) by aminoacid precipitation","volume":"11","author":"Wagner R H","year":"1964","journal-title":"Thromb Diath Haemorrh"},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V53.6.1095.1095","article-title":"Comparison of factor VIII\u2010related von Willebrand factor proteins prepared from human cryoprecipitate and factor VIII concentrate","volume":"53","author":"Weinstein M.","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1976.16376225490.x"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4117.1149"},{"key":"e_1_2_1_49_1","first-page":"79","article-title":"The comparative studies on factor XIII of newborn infants obtained by three methods; clot solubility, immunological and fluorescent assaies","volume":"39","author":"Yamada K.","year":"1976","journal-title":"Acta Haematol Jap"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(78)90268-2"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1980.tb01593.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1980.tb01593.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T02:14:14Z","timestamp":1711678454000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1980.tb01593.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1980,8]]}},"alternative-id":["10.1111\/j.1600-0609.1980.tb01593.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1980.tb01593.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1980,8]]}}}